Morgan Stanley’s Cardiol Therapeutics CRDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Buy |
99,881
+40,268
| +68% | +$54.8K | ﹤0.01% | 6014 |
|
|
2025
Q1 | $57.8K | Sell |
59,613
-144,930
| -71% | -$141K | ﹤0.01% | 6222 |
|
|
2024
Q4 | $262K | Buy |
204,543
+140,843
| +221% | +$180K | ﹤0.01% | 5684 |
|
|
2024
Q3 | $126K | Buy |
63,700
+36,400
| +133% | +$72.1K | ﹤0.01% | 5907 |
|
|
2024
Q2 | $55.1K | Buy |
+27,300
| New | +$55.1K | ﹤0.01% | 6138 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$90 | – | 7842 |
|
|
2023
Q3 | $90 | Buy |
+100
| New | +$90 | ﹤0.01% | 7452 |
|
|
2023
Q1 | – | Sell |
-4,482
| Closed | -$2.29K | – | 7734 |
|
|
2022
Q4 | $2.29K | Sell |
4,482
-13,985
| -76% | -$7.13K | ﹤0.01% | 7336 |
|
|
2022
Q3 | $19K | Buy |
18,467
+12,664
| +218% | +$13K | ﹤0.01% | 6817 |
|
|
2022
Q2 | $7K | Buy |
5,803
+1,303
| +29% | +$1.57K | ﹤0.01% | 7310 |
|
|
2022
Q1 | $7K | Sell |
4,500
-4,551
| -50% | -$7.08K | ﹤0.01% | 7495 |
|
|
2021
Q4 | $17K | Sell |
9,051
-18,039
| -67% | -$33.9K | ﹤0.01% | 7272 |
|
|
2021
Q3 | $112K | Buy |
+27,090
| New | +$112K | ﹤0.01% | 6303 |
|